Spectrum Pharmaceuticals, Inc. (SPPI) Announces Initiation of a Required Phase 1 Study of Apaziquone in Japan by Nippon Kayaku Co., Ltd.
1/6/2011 9:42:34 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Receipt of $16 Million from Asian Partners, Such As Nippon Kayaku Co., Ltd. Related to Apaziquone Collaboration Agreements Announced in November 2009
1/29/2010 7:55:39 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) and Nippon Kayaku Co., Ltd. Enter Collaboration Agreement for Apaziquone in Asian Territories
11/10/2009 9:17:16 AM
More...
|
BioSphere Medical, Inc. (BSMD) Enters into Exclusive Distribution Agreement with Nippon Kayaku Co., Ltd. for Japanese Market
4/16/2009 8:21:00 AM
More...
|
Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
7/17/2008 7:37:51 AM
More...
|
NeoPharm (NEOL) Says Japan's Nippon Kayaku Co., Ltd. Terminates License Agreement
9/14/2007 8:08:14 AM
More...
|
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan
9/21/2006 3:44:33 PM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces A License And Collaboration Agreement For Ozarelix With Nippon Kayaku Co., Ltd. For The Japanese Market
8/4/2006 11:06:54 AM
More...
|
AEterna Zentaris (AEZS) Enters A License And Collaboration Agreement For Ozarelix With Nippon Kayaku Co., Ltd. For The Japanese Market
8/3/2006 10:39:28 AM
More...
|
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. Receive Approval For Cetrotide
4/21/2006 10:30:48 AM
More...
|
|